Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2008
10/21/2008US7439370 Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
10/21/2008US7439242 PPARγ modulators
10/21/2008CA2330974C Energy transfer assay method and reagent
10/16/2008WO2008123914A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
10/16/2008WO2008123821A1 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008122352A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008US20080255218 N-benzylamino cyclic thioureas; obesity and related disorders; (N-(3-{(4S)-1-[(1S)-2-(benzylamino)-1-methylethyl]-3-[2-(3-fluorophenyl)ethyl]-2-thioxoimidazolidin-4-yl}propyl)guanidine
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255120 Substituted 2,5-heterocyclic derivatives
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255073 Compounds for sustained release of orally delivered drugs
10/16/2008US20080251754 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
10/16/2008DE102007058429A1 Verbindungen und Schmiermittelzusammensetzungen, die diese Verbindungen enthalten Compounds and lubricant compositions containing these compounds
10/16/2008CA2682875A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008CA2681864A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1685114B1 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines.
10/15/2008EP1497267B1 Method for the production of chiral imidazolidin-2-ones
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008CN101287711A Method for producing 1-substituted-5-acylimidazole compound
10/15/2008CN101284818A Solid forms of (E) -1- (4- ( (1R, 2S, 3R) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime
10/15/2008CN101284817A Methods of preparing imidazole-based compounds
10/15/2008CN101284816A Chiral N-2-(glyoxaline-1-group) fatty acid amide and method for preparing same
10/15/2008CN101284211A Glyoxaline ion liquid reclaiming agent regeneration and cyclic utilization method
10/15/2008CN100425607C Method for controlling particular insects by applying anthranilamide compounds
10/14/2008US7435815 Sulfonylamino-acetic acid derivatives
10/09/2008WO2008120800A1 Method for producing 2-haloimidazole compound
10/09/2008WO2008119825A2 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119238A1 Substituted five membered heterocycle compounds, preparation method and medical use thereof
10/09/2008WO2008098886A3 Method for producing (meth)acrylates of n-hydroxyalkylated imidazoles
10/09/2008WO2008093272A3 Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures
10/09/2008WO2008074679A3 4-imidazolines as taar's ligands
10/09/2008WO2008054454A3 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
10/09/2008US20080249316 Receptor antagonist of advanced glycosylation endproducts ; antiinflammatory agents; Alzheimer's disease; anticancer, antitumor agent; autoimmune disease; antiarthritic agents; multiple sclerosis; diabetic nephropathy; cardiovascular disorders; osteoporosis
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080249131 treatment of HIV; N-(2-Bromo-4-methylphenyl)-2-(5-methyl-4-phenyl-4H-[1,2,4]triazole-3-ylsulfanyl)-acetamide
10/09/2008CA2682649A1 Imidazolidine carboxamide derivatives as p2x7 modulators
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976834A2 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976832A2 Azole compounds used as tuberculostatic and leishmanicide agents
10/08/2008EP1781596B1 Amino acid derived prodrugs of propofol compositions and uses thereof
10/08/2008CN101282942A Imidazole derivatives for the treatment of anxiety and related diseases
10/08/2008CN101282941A Imidazole compounds for the treatment of neurological disorders
10/08/2008CN101282940A Fluorinated compounds
10/08/2008CN101282937A Therapeutic agents
10/08/2008CN101279952A Method for preparing 1,3-dimethyl alkyleneurea by methylation by step
10/08/2008CN101279947A Synthetic method of (4S,5R)-half-ester
10/08/2008CN100424259C Room temperature ionic liquid containing unsaturated double bond and its prepn and application
10/07/2008US7432302 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
10/07/2008US7432295 18F fluorine compounds, especially N-fluoroalkyl- or fluoroalkenylene-substituted 2-(2-Nitro-1H-imidazol-1-yl)acetamides, useful for non-invasive imaging techniques such as PET
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008US7432254 Method for treating glaucoma IC
10/07/2008US7432058 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
10/07/2008CA2362831C Thioamide derivatives
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008067981A3 Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
10/02/2008US20080242838 Multifunctional labels in proteomics; lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies
10/02/2008US20080242716 Ion Channel Modulators
10/02/2008US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080242639 Phosphagen Synthesis
10/02/2008US20080241896 Process for production of optically active hydroxymethyl-substituted phenylalanine
10/02/2008CA2681431A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of .beta.-secretase
10/01/2008EP1975157A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP
10/01/2008EP1973890A2 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/01/2008EP1973884A2 Novel heterocycles
10/01/2008EP1973656A1 Heterogeneous chiral catalyst
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101274913A Ornidazole sodium succinate compound, medicinal composition and use thereof
10/01/2008CN101274912A Separation and purification method for 15N-L-histidine
10/01/2008CN101273988A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
10/01/2008CN100422175C 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
09/2008
09/30/2008US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008CA2314009C Triazole and imidazole derivatives
09/30/2008CA2303848C Substituted anilides
09/25/2008WO2008115552A1 AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5- PHENYLIMIDAZOLONE COMPOUNDS AS ß-SECRETASE INHIBITORS
09/25/2008WO2008115250A2 Fluid storage and purification method and system using ionic liquid in particular di-imidazolium cation
09/25/2008WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
09/25/2008WO2008114584A1 Treating agent for polysaccharide
09/25/2008US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
09/25/2008US20080234271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them
09/25/2008US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis
09/25/2008US20080234202 Reacting carboxylic acid or amide derivative with amine compound to obtain amino acid analogs, peptides containing analogs of basic amino acids lysine and arginine; desamino amino acid compound, of the extended or truncated peptide; pain, psychosis, obesity; cosmetics
09/25/2008CA2681243A1 Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as .beta.-secretase inhibitors
09/24/2008EP1465877B1 Positive-working photoimageable bottom antireflective coating
09/24/2008CN101273018A Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE)
09/24/2008CN101271089A Application of allantoin in Cistanche plant variety identification and its novel use for decreasing blood fat
09/24/2008CN101270088A Chemical synthesis method for 2-imidazole alkyl ketone
09/24/2008CN100420677C Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use
09/24/2008CN100420675C Transesterification process for production of (meth)acrylate ester monomers
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 345